Applied Genetic Technologies (AGTC) Tops Q4 EPS by $0.12

Applied Genetic Technologies (NASDAQ: AGTC) reported Q4 EPS of ($0.28), $0.12 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $500K.

As of June 30, 2021, the Company's cash, cash equivalents and investments totaled $107.1 million.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c